See more : Jervois Global Limited (JRV.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Harvest Health & Recreation Inc. (HRVSF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Harvest Health & Recreation Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- I Yuan Precision Industrial Co., Ltd. (2235.TWO) Income Statement Analysis – Financial Results
- The Toronto-Dominion Bank (TD-PFK.TO) Income Statement Analysis – Financial Results
- LaserBond Limited (LBL.AX) Income Statement Analysis – Financial Results
- Minth Group Limited (MNTHY) Income Statement Analysis – Financial Results
- Ubisoft Entertainment SA (UBI.PA) Income Statement Analysis – Financial Results
Harvest Health & Recreation Inc. (HRVSF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: http://www.harvesthoc.com
About Harvest Health & Recreation Inc.
Harvest Health and Recreation, Inc., together with its subsidiaries, cultivates, processes, sells, and retails inhalable, ingestible, and topical cannabis products in the United States. The company offers cannabis oil products; inhalables, including flower, dabbable concentrates, pre-filled vaporizer pens, and cartridges; and capsules, tinctures, and cannabis product edibles, including chocolates, gummies, mints, fruit chews, and dissolvable mouth strips under the Avenue, CBX SCIENCES, EVOLAB, ALCHEMY, CHROMA, CO2LORS, GOODSUN, MODERN FLOWER, and ROLL ONE brand names. It also operates retail dispensaries that sell proprietary and third-party cannabis products to patients and customers; and provides support services and financing to a Utah licensed medical cannabis cultivator. Harvest Health and Recreation, Inc. was founded in 2011 and is headquartered in Tempe, Arizona.
Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 231.46M | 116.78M | 77.79K | 200.29K | 284.45K | 482.02K | 675.22K | 368.83K | 292.64K | 233.88K | 180.62K | 147.97K | 24.10K |
Cost of Revenue | 129.87M | 73.21M | 15.89K | 56.47K | 31.73K | 94.81K | 160.79K | 51.74K | 269.58K | 478.39K | 372.72K | 1.23M | 14.92K |
Gross Profit | 101.59M | 43.57M | 61.91K | 143.82K | 252.72K | 387.20K | 514.43K | 317.09K | 23.05K | -244.51K | -192.10K | -1.08M | 9.18K |
Gross Profit Ratio | 43.89% | 37.31% | 79.58% | 71.81% | 88.84% | 80.33% | 76.19% | 85.97% | 7.88% | -104.55% | -106.36% | -728.50% | 38.10% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 122.10M | 115.86M | 83.35K | 65.96K | 78.32K | 129.18K | 251.07K | 246.79K | 446.60K | 505.30K | 498.98K | 498.25K | 0.00 |
Selling & Marketing | 4.96M | 8.94M | 0.00 | 0.00 | 0.00 | 0.00 | 1.40K | 0.00 | 1.26K | 0.00 | 10.93K | 0.00 | 0.00 |
SG&A | 127.06M | 124.80M | 83.35K | 65.96K | 78.32K | 129.18K | 252.46K | 246.79K | 447.86K | 505.30K | 509.91K | 498.25K | 0.00 |
Other Expenses | 7.92M | 10.30M | 93.75K | 126.55K | 300.84K | 408.79K | 308.00K | 180.03K | 55.80K | 0.00 | 0.00 | 0.00 | 1.46M |
Operating Expenses | 134.98M | 135.10M | 177.10K | 192.51K | 379.15K | 537.97K | 560.47K | 426.82K | 503.65K | 505.30K | 509.91K | 498.25K | 1.46M |
Cost & Expenses | 264.85M | 208.30M | 192.98K | 248.98K | 410.89K | 632.79K | 721.26K | 478.56K | 773.24K | 983.69K | 882.64K | 1.72M | 1.48M |
Interest Income | 444.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 60.03 | 615.56 | 568.96 | 1.21K | 1.98K | 9.68K | 1.53K |
Interest Expense | 39.06M | 16.24M | 4.78K | 5.50K | 3.34K | 5.27K | 6.99K | 10.34K | 32.61K | 27.68K | 16.64K | 2.28K | 0.00 |
Depreciation & Amortization | 16.67M | 12.69M | 2.93K | 5.22K | 3.29K | 13.51K | 24.44K | 6.09K | 55.80K | 200.11K | 165.86K | 991.47K | 651.57K |
EBITDA | -259.00K | -140.80M | -347.62K | -43.47K | -109.40K | -110.67K | -219.74K | -125.25K | -25.86K | -645.52K | -1.56M | -575.04K | -801.24K |
EBITDA Ratio | -0.11% | -120.57% | -446.85% | -21.71% | -38.46% | -22.96% | -32.54% | -33.96% | -8.84% | -276.01% | -866.36% | -388.63% | -3,324.16% |
Operating Income | -33.39M | -91.52M | -115.19K | -48.69K | -126.44K | -150.77K | -46.04K | -109.73K | -480.60K | -749.81K | -702.02K | -1.58M | -1.45M |
Operating Income Ratio | -14.43% | -78.37% | -148.07% | -24.31% | -44.45% | -31.28% | -6.82% | -29.75% | -164.23% | -320.60% | -388.67% | -1,065.22% | -6,033.34% |
Total Other Income/Expenses | -21.26M | -80.29M | -240.14K | -5.50K | 10.40K | 21.32K | -205.13K | -31.96K | 366.34K | -97.03K | -933.72K | 0.00 | 0.00 |
Income Before Tax | -54.65M | -171.81M | -355.33K | -54.19K | -116.04K | -129.45K | -251.17K | -141.69K | -114.26K | -846.84K | -1.64M | 0.00 | 0.00 |
Income Before Tax Ratio | -23.61% | -147.12% | -456.76% | -27.06% | -40.79% | -26.86% | -37.20% | -38.42% | -39.05% | -362.08% | -905.63% | 0.00% | 0.00% |
Income Tax Expense | 3.65M | 3.76M | -235.36K | 0.00 | 13.75K | 26.59K | -198.14K | -21.61K | 398.95K | -69.35K | -917.09K | 2.28K | 0.00 |
Net Income | -59.63M | -173.49M | -355.33K | -54.19K | -116.04K | -129.45K | -251.17K | -141.69K | -114.26K | -873.31K | -1.75M | -1.57M | -1.45M |
Net Income Ratio | -25.76% | -148.56% | -456.76% | -27.06% | -40.79% | -26.86% | -37.20% | -38.42% | -39.05% | -373.40% | -967.40% | -1,060.22% | -6,027.36% |
EPS | -0.17 | -0.61 | -0.08 | -0.01 | -0.03 | -0.03 | -0.06 | -0.04 | -0.04 | -0.42 | -1.23 | -1.53 | -3.86 |
EPS Diluted | -0.17 | -0.61 | -0.08 | -0.01 | -0.03 | -0.03 | -0.06 | -0.04 | -0.04 | -0.42 | -1.23 | -1.53 | -3.86 |
Weighted Avg Shares Out | 354.76M | 286.63M | 4.59M | 4.00M | 4.00M | 4.00M | 3.95M | 3.22M | 2.79M | 2.09M | 1.43M | 1.03M | 376.52K |
Weighted Avg Shares Out (Dil) | 354.76M | 286.63M | 4.59M | 4.00M | 4.00M | 4.00M | 3.95M | 3.22M | 2.79M | 2.09M | 1.43M | 1.03M | 376.52K |
The Smartest Penny Stocks to Buy Right Now
4 Stocks Wall Street Expects Will Nearly Triple in 1 Year
Trulieve Cannabis Co. Completes HSR Milestone, Moves One Step Closer To $2.1B Harvest Health Deal
Why Trulieve's Acquisition of Harvest Health Could Pay Off Big-Time
Dispensary Roundup: Harvest Health Opens Two Shops In Fla., SKYMINT In Michigan, Cresco And Ayr Wellness Open One Store Each in PA
Current State Of Cannabis (Podcast Transcript)
Master Class In Cannabis Investing, Part 3 (Podcast Transcript)
Current State Of Cannabis (Podcast)
Master Class In Cannabis Investing, Part 3 (Podcast)
3 Winning Cannabis Stocks You Can Buy for Less Than $50
Source: https://incomestatements.info
Category: Stock Reports